VanEck Pharmaceutical ETF (PPH)

NasdaqGM

114.55
+1.47 (+1.30%)
Updated Sep 1, 6:15 PM ET
AI Rating
Buy
Overall Score
69
Trend
97
Momentum
43
Risk
61

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 18, 2025 260 sessions Aug 28, 2026

AI Analysis

VanEck Pharmaceutical ETF is trading at $114.55, up 1.30% on the session. The 50 day average sits at $110.61 and the 200 day at $105.64, which puts the stock in a uptrend. RSI is at 52.4, which reads as neutral, and MACD is bearish crossover. Volume is average.

The nearest support is around $109.88 with resistance near $114.57, so that band frames the current range. Average daily movement is roughly $1.94, or about 1.7% of the share price, which is what any stop placement has to allow for. The overall health score of 69 out of 100 combines a trend score of 97, momentum of 43 and a risk score of 61.

Technical indicators

RSI (14)
52.4
neutral
MACD
1.511
bearish crossover
SMA 20
112.91
SMA 50
110.61
SMA 200
105.64
uptrend
ATR (14)
1.94
avg daily range
Support
109.88
Resistance
114.57
Volume vs 20d
1.04x
average
Volatility
22.2%
annualised
1 month
+1.81%
3 months
+8.48%

About VanEck Pharmaceutical ETF

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.